Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.965 USD | -0.17% | -2.61% | -8.42% |
Apr. 24 | Gain Therapeutics, Inc. Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287 | CI |
Apr. 08 | Gain Therapeutics Names Gene Mack as CFO | MT |
- Stock Market
- Equities
- GANX Stock
- News Gain Therapeutics, Inc.
- Trading Ideas